We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Bill & Melinda Gates Foundation announced 16 grants totaling $287 million to create an international network of highly collaborative research consortia focused on accelerating the pace of HIV vaccine development.
The FDA has approved several first generic versions of Boehringer Ingelheim's Mobic Tablets, indicated for the treatment of osteoarthritis, an important step in the agency's effort to increase the availability of lower-cost generic medications.
Momentum is growing at the UK's new National Biomanufacturing Centre (NBC) as Eden Biodesign inked a second contract at the center set up to establish Northwest England as one of the top biomanufacturing hubs in Europe.
U. S. Department of Health and Human Services (HHS) Secretary Mike Leavitt and Vietnamese Minister of Health Tran Thi Trung Chien have signed an agreement promising continued cooperation on health issues, including emerging diseases, avian and pandemic influenza and HIV/AIDS.
An agreement to enhance bilateral cooperation between India and Fiji Islands in the field of health and medicine was approved by the Union Cabinet today.
The Japanese pharmaceutical industry is eyeing India as a new hub to conduct its contract manufacturing and clinical trials -- India is thirsty for new Japanese investment.
ImClone Systems Incorporated and Merck KGaA, Darmstadt, Germany, announced today that they have entered into agreements amending and supplementing the 1998 development and license agreement covering ERBITUX and certain other work in the field of EGFR-targeted antibodies.
Aspreva Pharmaceuticals Corporation reports that Mycophenolate Mofetil (MMF, CellCept(R)) has been approved for the treatment of lupus nephritis in Malaysia.
Ranbaxy Laboratories Limited's wholly owned subsidiary, Ranbaxy Pharmaceuticals Canada Inc. (RPCI) and Janssen-Ortho Inc. (JOI), have entered into a licensing and supply agreement for a generic version of risperidone compressed tablets, sold under Ranbaxy's label, Ran Risperidone.